New therapies in chronic prostatitis.
The optimal management of category III prostatitis (chronic pelvic pain syndrome) is not known. Conventional therapy usually consists of prolonged courses of antibiotics; however, clinical trials have never shown their efficacy. Newer therapies with some evidence for efficacy include alpha-blockers, anti-inflammatory phytotherapy (quercetin, bee pollen), physiotherapy, neuroleptics, and others with unique actions such as antinanobacterial treatment. A stepwise approach involving multiple treatment modalities is often successful for patients with this common and frustrating condition.
Glickman Urological Institute, Cleveland Clinic Foundation, 9500 Euclid Avenue, Desk A100, Cleveland OH 44195, USA.
Nivedita Bhatta
NB
Dhar
Daniel A
DA
Shoskes
D000465:Algorithms; D002908:Chronic Disease; D006801:Humans; D008297:Male; D017699:Pelvic Pain / Q000628:therapy*; D011472:Prostatitis / Q000628:therapy*; D013577:Syndrome